Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil Doses on Stress Response in Laparoscopic Cholecystectomy
NCT03378674Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Jan 2008
- Primary completion
- Jul 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of remifentanil in Surgical stress response, sponsored by Università Cattolica del Sacro Cuore. Primary endpoint: Adrenocorticotropic hormone. Started Jan 2008; status: completed.
02
Drugs
remifentanil
03
Conditions
Surgical stress response
Beyond the preview
Go deeper on NCT03378674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03378674.